PuSH - Publication Server of Helmholtz Zentrum München

20 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Akmatov, M.F.* et al.: Determination of nasal and oropharyngeal microbiomes in a multicenter population-based study - findings from Pretest 1 of the German National Cohort. Sci. Rep. 7:1855 (2017)
2.
Akmatov, M.K.* et al.: Anti-nuclear autoantibodies in the general German population: Prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based study. Arthritis Res. Ther. 19:127 (2017)
3.
Day, F.R.* et al.: Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nat. Genet. 49, 834-841 (2017)
4.
Fehringer, G.* et al.: Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations. Cancer Res. 76, 5103-5114 (2016)
5.
Day, F.R.* et al.: Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nat. Genet. 47, 1294-1303 (2015)
6.
Day, F.R.* et al.: Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility, and BRCA1-mediated DNA repair. Obstet. Gynecol. 70, 758-762 (2015)
7.
Khan, S.* et al.: MicroRNA related polymorphisms and breast cancer risk. PLoS ONE 9:e109973 (2014)
8.
Perry, J.R.B.* et al.: Parent-of-origin specific allelic associations among 106 genomic1 loci for age at menarche. Nature 514, 92-97 (2014)
9.
Seibold, P.* et al.: Enterolactone concentrations and prognosis after postmenopausal breast cancer: Assessment of effect modification and meta-analysis. Int. J. Cancer 135, 923-933 (2014)
10.
French, J.D.* et al.: Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am. J. Hum. Genet. 92, 489-503 (2013)
11.
Garcia-Closas, M.* et al.: Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat. Genet. 45, 392-398 (2013)
12.
Hein, R.* et al.: A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: A two-stage design with replication. Breast Cancer Res. Treat. 138, 529-542 (2013)
13.
Michailidou, K.* et al.: Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet. 45, 353-361 (2013)
14.
Seibold, P.* et al.: Enterolactone levels and prognosis after invasive postmenopausal breast cancer: Potential effect modifiers. Cancer Res. 73:115 (2013)
15.
Ghoussaini, M.* et al.: Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat. Genet. 44, 312-319 (2012)
16.
Siddiq, A.* et al.: A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum. Mol. Genet. 21, 5373-5384 (2012)
17.
Zaineddin, A.K.* et al.: Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status. Int. J. Cancer 130, 1401-1410 (2012)
18.
Zaineddin, A.K.* et al.: The association between dietary lignans, phytoestrogen-rich foods, and fiber intake and postmenopausal breast cancer risk: A German case-control study. Nutr. Cancer 64, 652-665 (2012)
19.
Buck, K.* et al.: Serum enterolactone and prognosis of postmenopausal breast cancer. J. Clin. Oncol. 29, 3730-3738 (2011)
20.
Buck, K.* et al.: Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer. Br. J. Cancer 105, 1151-1157 (2011)